{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:45:52Z","timestamp":1792539952576,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s13555-025-01375-5","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T04:03:00Z","timestamp":1745294580000},"page":"1371-1390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Association Between Atopic Dermatitis and Select Disease Events in Adults in the United States: A Retrospective Cohort Study in the Optum Electronic Health Records Database"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2994-1341","authenticated-orcid":false,"given":"Adina R.","family":"Lemeshow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Egeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Schachterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela E.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shefali","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"issue":"1","key":"1375_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","volume":"4","author":"S Weidinger","year":"2018","unstructured":"Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nat Rev Dis Primers. 2018;4(1):1.","journal-title":"Nat Rev Dis Primers"},{"issue":"10247","key":"1375_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","volume":"396","author":"SM Langan","year":"2020","unstructured":"Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396(10247):345\u201360.","journal-title":"Lancet"},{"issue":"3","key":"1375_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jid.2018.08.028","volume":"139","author":"ZC Chiesa Fuxench","year":"2019","unstructured":"Chiesa Fuxench ZC, Block JK, Boguniewicz M, et al. Atopic Dermatitis in America Study: a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population. J Invest Dermatol. 2019;139(3):583\u201390.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"1375_CR4","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/all.13401","volume":"73","author":"S Barbarot","year":"2018","unstructured":"Barbarot S, Auziere S, Gadkari A, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73(6):1284\u201393.","journal-title":"Allergy"},{"issue":"5","key":"1375_CR5","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.jaip.2019.01.005","volume":"7","author":"JI Silverberg","year":"2019","unstructured":"Silverberg JI, Gelfand JM, Margolis DJ, et al. Atopic dermatitis in US adults: from population to health care utilization. J Allergy Clin Immunol Pract. 2019;7(5):1524-32.e2.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"1375_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/1346-8138.15664","volume":"48","author":"T Nakahara","year":"2021","unstructured":"Nakahara T, Kido-Nakahara M, Tsuji G, Furue M. Basics and recent advances in the pathophysiology of atopic dermatitis. J Dermatol. 2021;48(2):130\u20139.","journal-title":"J Dermatol"},{"issue":"9","key":"1375_CR7","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/jdv.18225","volume":"36","author":"T Bieber","year":"2022","unstructured":"Bieber T, Paller AS, Kabashima K, et al. Atopic dermatitis: pathomechanisms and lessons learned from novel systemic therapeutic options. J Eur Acad Dermatol Venereol. 2022;36(9):1432\u201349.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1375_CR8","first-page":"97","volume":"16","author":"M Furue","year":"2019","unstructured":"Furue M, Ulzii D, Vu YH, Tsuji G, Kido-Nakahara M, Nakahara T. Pathogenesis of atopic dermatitis: current paradigm. Iran J Immunol. 2019;16(2):97\u2013107.","journal-title":"Iran J Immunol"},{"issue":"8","key":"1375_CR9","volume":"12","author":"Z Hassan","year":"2020","unstructured":"Hassan Z, Luvsannyam E, Patel D, Nukala S, Puvvada SR, Hamid P. Review of prominent cytokines as superior therapeutic targets for moderate-to-severe atopic dermatitis. Cureus. 2020;12(8): e9901.","journal-title":"Cureus"},{"issue":"6","key":"1375_CR10","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.jaad.2022.01.009","volume":"86","author":"DMR Davis","year":"2022","unstructured":"Davis DMR, Drucker AM, Alikhan A, et al. AAD guidelines: awareness of comorbidities associated with atopic dermatitis in adults. J Am Acad Dermatol. 2022;86(6):1335\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1375_CR11","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.jid.2017.01.030","volume":"137","author":"SM Langan","year":"2017","unstructured":"Langan SM, Abuabara K, Henrickson SE, Hoffstad O, Margolis DJ. Increased risk of cutaneous and systemic infections in atopic dermatitis-a cohort study. J Investig Dermatol. 2017;137(6):1375\u20137.","journal-title":"J Investig Dermatol"},{"issue":"1","key":"1375_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13671-017-0168-7","volume":"6","author":"YMF Andersen","year":"2017","unstructured":"Andersen YMF, Egeberg A, Skov L, Thyssen JP. Comorbidities of atopic dermatitis: beyond rhinitis and asthma. Curr Dermatol Rep. 2017;6(1):35\u201341.","journal-title":"Curr Dermatol Rep"},{"issue":"1","key":"1375_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jaci.2016.01.015","volume":"138","author":"YMF Andersen","year":"2016","unstructured":"Andersen YMF, Egeberg A, Gislason GH, Hansen PR, Skov L, Thyssen JP. Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis. J Allergy Clin Immunol. 2016;138(1):310-2.e3.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1375_CR14","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s13555-021-00538-4","volume":"11","author":"KJ Meyers","year":"2021","unstructured":"Meyers KJ, Silverberg JI, Rueda MJ, et al. Risk of venous thromboembolism among patients with atopic dermatitis: a cohort study in a US administrative claims database. Dermatol Ther (Heidelb). 2021;11(3):1041\u201352.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"11","key":"1375_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0277469","volume":"17","author":"MM Hedderson","year":"2022","unstructured":"Hedderson MM, Asgari MM, Xu F, et al. Rates of cardiovascular events among patients with moderate-to-severe atopic dermatitis in an integrated health care system: a retrospective cohort study. PLoS ONE. 2022;17(11): e0277469.","journal-title":"PLoS ONE"},{"key":"1375_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1786","volume":"361","author":"RJ Silverwood","year":"2018","unstructured":"Silverwood RJ, Forbes HJ, Abuabara K, et al. Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study. Br Med J. 2018;361: k1786.","journal-title":"Br Med J"},{"issue":"10","key":"1375_CR17","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/all.12685","volume":"70","author":"JI Silverberg","year":"2015","unstructured":"Silverberg JI. Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies. Allergy. 2015;70(10):1300\u20138.","journal-title":"Allergy"},{"issue":"3","key":"1375_CR18","volume":"13","author":"MM Hedderson","year":"2023","unstructured":"Hedderson MM, Asgari MM, Xu F, et al. Rates of malignancies among patients with moderate to severe atopic dermatitis: a retrospective cohort study. Br Med J Open. 2023;13(3): e071172.","journal-title":"Br Med J Open"},{"issue":"10","key":"1375_CR19","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1001\/jamadermatol.2020.1948","volume":"156","author":"KE Mansfield","year":"2020","unstructured":"Mansfield KE, Schmidt SAJ, Darvalics B, et al. Association between atopic eczema and cancer in England and Denmark. JAMA Dermatol. 2020;156(10):1086\u201397.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"1375_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018530","volume":"99","author":"WY Chou","year":"2020","unstructured":"Chou WY, Lai PY, Hu JM, et al. Association between atopic dermatitis and colorectal cancer risk: a nationwide cohort study. Medicine (Baltimore). 2020;99(1): e18530.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1375_CR21","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/bjd.20887","volume":"186","author":"J Wan","year":"2022","unstructured":"Wan J, Shin DB, Syed MN, Abuabara K, Lemeshow AR, Gelfand JM. Risk of herpesvirus, serious and opportunistic infections in atopic dermatitis: a population-based cohort study. Br J Dermatol. 2022;186(4):664\u201372.","journal-title":"Br J Dermatol"},{"key":"1375_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jdin.2021.12.007","volume":"6","author":"R Fan","year":"2022","unstructured":"Fan R, Leasure AC, Damsky W, Cohen JM. Association between atopic dermatitis and COVID-19 infection: a case-control study in the All of Us research program. JAAD Int. 2022;6:77\u201381.","journal-title":"JAAD Int"},{"issue":"2","key":"1375_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4168\/aair.2023.15.2.231","volume":"15","author":"SW Lee","year":"2023","unstructured":"Lee SW, Kim H, Byun Y, et al. Incidence of cardiovascular disease after atopic dermatitis development: a nationwide, population-based study. Allergy Asthma Immunol Res. 2023;15(2):231\u201345.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"4","key":"1375_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/bjd\/ljad212","volume":"189","author":"RB Warren","year":"2023","unstructured":"Warren RB, Basey V, Lynam A, Curtis C, Ardern-Jones MR. The risk of venous thromboembolism in atopic dermatitis: a matched cohort analysis in UK primary care. Br J Dermatol. 2023;189(4):427\u201336.","journal-title":"Br J Dermatol"},{"issue":"7","key":"1375_CR25","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1001\/jamadermatol.2023.1300","volume":"159","author":"TL Chen","year":"2023","unstructured":"Chen TL, Huang WT, Loh CH, Huang HK, Chi CC. Risk of venous thromboembolism among adults with atopic dermatitis. JAMA Dermatol. 2023;159(7):720\u20137.","journal-title":"JAMA Dermatol"},{"key":"1375_CR26","unstructured":"Optum Inc. The Optum EHR offering. 2020. https:\/\/www.optum.com\/content\/dam\/optum3\/optum\/en\/landing\/ls\/DRN\/DRNProduct\/EHR-offering.pdf. Accessed 28 January 2025."},{"key":"1375_CR27","unstructured":"Optum Inc. Is your real-world data research ready? 2022. www.optum.com.br\/content\/dam\/optum3\/optum\/en\/resources\/PDFs\/wf4251723-data-quality-white-paper.pdf. Accessed 28 Jan 2025."},{"key":"1375_CR28","unstructured":"Optum Inc. Gain visibility into patient care and outcomes with EHR data. 2024. https:\/\/business.optum.com\/content\/dam\/o4-dam\/resources\/pdfs\/sell-sheets\/ehr-sell-sheet.pdf. Accessed 29 Jan 2025."},{"issue":"1","key":"1375_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/bjd\/ljad072","volume":"189","author":"J Wan","year":"2023","unstructured":"Wan J, Shin DB, Syed MN, et al. Malignancy risk in patients with atopic dermatitis: a population-based cohort study. Br J Dermatol. 2023;189(1):53\u201361.","journal-title":"Br J Dermatol"},{"issue":"10","key":"1375_CR30","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2340\/00015555-3235","volume":"99","author":"LU Ivert","year":"2019","unstructured":"Ivert LU, Johansson EK, Dal H, Lindel\u00f6f B, Wahlgren CF, Bradley M. Association between atopic dermatitis and cardiovascular disease: a nationwide register-based case-control study from Sweden. Acta Derm Venereol. 2019;99(10):865\u201370.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"1375_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jaad.2021.09.061","volume":"86","author":"JJ Wu","year":"2022","unstructured":"Wu JJ, Martin A, Liu J, et al. The risk of COVID-19 infection in patients with atopic dermatitis: a retrospective cohort study. J Am Acad Dermatol. 2022;86(1):243\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1375_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/09546634.2019.1659480","volume":"32","author":"KK Wu","year":"2021","unstructured":"Wu KK, Borba AJ, Deng PH, Armstrong AW. Association between atopic dermatitis and conjunctivitis in adults: a population-based study in the United States. J Dermatol Treat. 2021;32(4):455\u20139.","journal-title":"J Dermatol Treat"},{"issue":"2","key":"1375_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jaad.2014.03.030","volume":"71","author":"R Sidbury","year":"2014","unstructured":"Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327\u201349.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1375_CR34","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.anai.2021.09.004","volume":"127","author":"TL Lin","year":"2021","unstructured":"Lin TL, Wu CY, Yen JJ, et al. Fracture risks in patients with atopic dermatitis: a nationwide matched cohort study. Ann Allergy Asthma Immunol. 2021;127(6):667-73.e2.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1375_CR35","unstructured":"Hao J, Maeng D, Yan S, Stewart W, Boscarino JA. Assessing healthcare utilization and cost of care among rheumatoid arthritis patients: a comparison of electronic medical records and claims data. J Health Care Financ. 2017;43."},{"issue":"1","key":"1375_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.anai.2020.08.002","volume":"126","author":"V Wang","year":"2021","unstructured":"Wang V, Boguniewicz J, Boguniewicz M, Ong PY. The infectious complications of atopic dermatitis. Ann Allergy Asthma Immunol. 2021;126(1):3\u201312.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"1375_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/cea.13537","volume":"50","author":"AB Muir","year":"2020","unstructured":"Muir AB, Whelan KA, Dougherty MK, et al. The potential for malignancy from atopic disorders and allergic inflammation: a systematic review and meta-analysis. Clin Exp Allergy. 2020;50(2):147\u201359.","journal-title":"Clin Exp Allergy"},{"key":"1375_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.coi.2014.01.001","volume":"27","author":"NA Giraldo","year":"2014","unstructured":"Giraldo NA, Becht E, Remark R, et al. The immune contexture of primary and metastatic human tumours. Curr Opin Immunol. 2014;27:8\u201315.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"1375_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27\u201341.","journal-title":"Immunity"},{"issue":"2","key":"1375_CR40","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1001\/jamadermatol.2019.3786","volume":"156","author":"L Wang","year":"2020","unstructured":"Wang L, Bierbrier R, Drucker AM, Chan A-W. Noncutaneous and cutaneous cancer risk in patients with atopic dermatitis: a systematic review and meta-analysis. JAMA Dermatol. 2020;156(2):158\u201371.","journal-title":"JAMA Dermatol"},{"issue":"10","key":"1375_CR41","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1016\/j.jaip.2023.08.007","volume":"11","author":"J Wan","year":"2023","unstructured":"Wan J, Fuxench ZCC, Wang S, et al. Incidence of cardiovascular disease and venous thromboembolism in patients with atopic dermatitis. J Allergy Clin Immunol Pract. 2023;11(10):3123\u201332.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"1375_CR42","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jaad.2018.03.017","volume":"79","author":"ATM Ronnstad","year":"2018","unstructured":"Ronnstad ATM, Halling-Overgaard AS, Hamann CR, Skov L, Egeberg A, Thyssen JP. Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: a systematic review and meta-analysis. J Am Acad Dermatol. 2018;79(3):448-56.e30.","journal-title":"J Am Acad Dermatol"},{"key":"1375_CR43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jad.2015.02.025","volume":"178","author":"CM Cheng","year":"2015","unstructured":"Cheng CM, Hsu JW, Huang KL, et al. Risk of developing major depressive disorder and anxiety disorders among adolescents and adults with atopic dermatitis: a nationwide longitudinal study. J Affect Disord. 2015;178:60\u20135.","journal-title":"J Affect Disord"},{"issue":"1","key":"1375_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.21037\/atm-20-4708","volume":"9","author":"D Wu","year":"2021","unstructured":"Wu D, Wu XD, Zhou X, Huang W, Luo C, Liu Y. Bone mineral density, osteopenia, osteoporosis, and fracture risk in patients with atopic dermatitis: a systematic review and meta-analysis. Ann Transl Med. 2021;9(1):40.","journal-title":"Ann Transl Med"},{"issue":"3","key":"1375_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jamadermatol.2020.4968","volume":"157","author":"A Egeberg","year":"2021","unstructured":"Egeberg A, Schwarz P, Harsl\u00f8f T, et al. Association of potent and very potent topical corticosteroids and the risk of osteoporosis and major osteoporotic fractures. JAMA Dermatol. 2021;157(3):275\u201382.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"1375_CR46","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jaip.2021.09.026","volume":"10","author":"J Matthewman","year":"2022","unstructured":"Matthewman J, Mansfield KE, Prieto-Alhambra D, et al. Atopic eczema-associated fracture risk and oral corticosteroids: a population-based cohort study. J Allergy Clin Immunol Pract. 2022;10(1):257-66.e8.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"1375_CR47","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.jaci.2020.12.001","volume":"147","author":"RJ Silverwood","year":"2021","unstructured":"Silverwood RJ, Mansfield KE, Mulick A, et al. Atopic eczema in adulthood and mortality: UK population-based cohort study, 1998\u20132016. J Allergy Clin Immunol. 2021;147(5):1753\u201363.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1375_CR48","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00403-022-02435-y","volume":"315","author":"S Iyer","year":"2023","unstructured":"Iyer S, Patel N, Sanfilippo E, Dellavalle RP, Silverberg JI. Assessment of the validity of international classification of disease tenth revision codes for atopic dermatitis. Arch Dermatol Res. 2023;315(4):879\u201384.","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"1375_CR49","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00403-021-02251-w","volume":"314","author":"RL Fulton","year":"2022","unstructured":"Fulton RL, Mitra N, Chiesa-Fuxench Z, Sockler PG, Margolis DJ. Untapping the potential of utilizing electronic medical records to identify patients with atopic dermatitis: an algorithm using ICD-10 codes. Arch Dermatol Res. 2022;314(5):439\u201344.","journal-title":"Arch Dermatol Res"},{"issue":"7","key":"1375_CR50","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/all.13113","volume":"72","author":"DY Hsu","year":"2017","unstructured":"Hsu DY, Dalal P, Sable KA, et al. Validation of international classification of disease ninth revision codes for atopic dermatitis. Allergy. 2017;72(7):1091\u20135.","journal-title":"Allergy"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01375-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-025-01375-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01375-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T17:03:18Z","timestamp":1747760598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-025-01375-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1375"],"URL":"https:\/\/doi.org\/10.1007\/s13555-025-01375-5","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Alexander Egeberg is currently employed by LEO Pharma and has previously received research funding from Pfizer Inc., AbbVie, Almirall, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly and Company, Novartis, Janssen, the Danish National Psoriasis Foundation, the Simon Spies Foundation, and the Kgl Hofbundtmager Aage Bang Foundation; and honoraria as consultant and\/or speaker from Pfizer Inc., AbbVie, Amgen, Almirall, Bristol-Myers Squibb, Boehringer Ingelheim, Dermavant, Eli Lilly and Company, Gal\u00e1pagos NV, Galderma, Horizon Therapeutics, Janssen, LEO Pharma, McNeil Consumer Healthcare, Mylan, Novartis, Samsung Bioepis Co., Ltd., Sun Pharmaceuticals, UCB, Union Therapeutics, and Zuellig Pharma Ltd. Thomas Edwards is an employee of Panalgo and received consultancy fees from Pfizer Inc. Jonathan I Silverberg has served as an investigator for Celgene, Eli Lilly and Company, F. Hoffmann-La Roche, Menlo Therapeutics, Realm Therapeutics, Regeneron Pharmaceuticals, and Sanofi Genzyme; as a consultant for Pfizer Inc., AbbVie, Anacor, AnaptysBio, Arena Pharmaceuticals, Dermavant, Dermira, Eli Lilly and Company, Galderma, GlaxoSmithKline, Glenmark, Incyte, Kiniksa Pharmaceuticals, LEO Pharma, Menlo Therapeutics, Novartis, Realm Therapeutics, Regeneron Pharmaceuticals, and Sanofi Genzyme; and as a speaker for Regeneron Pharmaceuticals and Sanofi Genzyme. Stephen E Schachterle, Daniela E Myers, and Adina R Lemeshow are employees and shareholders of Pfizer Inc. William Romero is currently employed by Eli Lilly and Company and was an employee and shareholder of Pfizer Inc. at the time of the study. Shefali Vyas is currently employed by AstraZeneca and was an employee and shareholder of Pfizer Inc. at the time of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This was a retrospective database study and was not subject to ethical review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}